Uganda Virus Research Institute
The Uganda Virus Research Institute (UVRI) is a leading research institution in Uganda that focuses on the study of viral infections and other infectious diseases. It is located in Entebbe, a town on the shores of Lake Victoria.
History
The UVRI was established in 1936 as the Yellow Fever Research Institute by the British Colonial Government to investigate the yellow fever outbreaks in the region. Over the years, the institute expanded its research scope to include other viral infections and was renamed the Uganda Virus Research Institute in 1977.
Research and Activities
The UVRI conducts extensive research on various viral diseases, including HIV/AIDS, Ebola virus disease, Marburg virus disease, influenza, and arboviruses such as dengue fever and chikungunya. The institute collaborates with several international organizations, including the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC).
The institute is also involved in public health initiatives, providing diagnostic services, conducting surveillance, and offering training programs for health professionals. The UVRI plays a crucial role in the monitoring and control of infectious diseases in Uganda and the surrounding regions.
Departments and Facilities
The UVRI is organized into several departments, each focusing on different aspects of viral research and public health:
- **Department of Arbovirology, Emerging and Re-emerging Infections**: Focuses on the study of arboviruses and other emerging infectious diseases.
- **Department of HIV Research**: Conducts research on HIV/AIDS, including epidemiology, prevention, and treatment.
- **Department of Immunology**: Studies the immune response to viral infections and develops vaccines.
- **Department of Entomology**: Investigates the role of insects in the transmission of viral diseases.
- **Department of Epidemiology and Surveillance**: Monitors the spread of infectious diseases and conducts outbreak investigations.
The institute is equipped with state-of-the-art laboratories and facilities, including a biosafety level 3 (BSL-3) laboratory for handling highly infectious pathogens.
Collaborations and Partnerships
The UVRI collaborates with various national and international organizations to enhance its research capabilities and public health impact. Some of its key partners include:
- World Health Organization (WHO)
- Centers for Disease Control and Prevention (CDC)
- National Institutes of Health (NIH)
- London School of Hygiene & Tropical Medicine
- Makerere University
These collaborations facilitate the exchange of knowledge, resources, and expertise, contributing to the global effort to combat infectious diseases.
Achievements
The UVRI has made significant contributions to the understanding and control of viral diseases. Some of its notable achievements include:
- Identification of new viral pathogens, including the Zika virus.
- Development of diagnostic tests for various viral infections.
- Conducting groundbreaking research on HIV/AIDS, leading to improved prevention and treatment strategies.
- Playing a key role in the response to Ebola and Marburg virus outbreaks in Uganda and neighboring countries.
Future Directions
The UVRI continues to expand its research portfolio and enhance its capacity to address emerging infectious diseases. Future directions for the institute include:
- Strengthening its research on antimicrobial resistance.
- Expanding its surveillance network to detect and respond to new viral threats.
- Enhancing its training programs to build local and regional capacity in viral research and public health.
See Also
- Entebbe
- Yellow fever
- HIV/AIDS
- Ebola virus disease
- Centers for Disease Control and Prevention
- World Health Organization
References
<references group="" responsive="1"></references>
External Links
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
